Tenofovir monotherapy versus tenofovir and entecavir combination therapy in patients with entecavir-resistant chronic hepatitis B with multiple drug failure: results of a randomised trial
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tenofovir monotherapy versus tenofovir and entecavir combination therapy in patients with entecavir-resistant chronic hepatitis B with multiple drug failure: results of a randomised trial
Authors
Keywords
-
Journal
GUT
Volume 65, Issue 5, Pages 852-860
Publisher
BMJ
Online
2015-01-17
DOI
10.1136/gutjnl-2014-308353
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
- (2015) JOURNAL OF HEPATOLOGY
- No Resistance to Tenofovir Disoproxil Fumarate Through 96 Weeks of Treatment in Patients With Lamivudine-Resistant Chronic Hepatitis B
- (2014) Amoreena C. Corsa et al. Clinical Gastroenterology and Hepatology
- Mortality, Liver Transplantation, and Hepatocellular Carcinoma Among Patients With Chronic Hepatitis B Treated With Entecavir vs Lamivudine
- (2014) Young–Suk Lim et al. GASTROENTEROLOGY
- Association of Nucleos(t)ide Analogue Therapy With Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B—A Nationwide Cohort Study
- (2014) Chun-Ying Wu et al. GASTROENTEROLOGY
- Efficacy of Adefovir-Based Combination Therapy for Patients with Lamivudine- and Entecavir-Resistant Chronic Hepatitis B Virus Infection
- (2013) Yun Bin Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antiviral Therapy for Chronic Hepatitis B Virus Infection and Development of Hepatocellular Carcinoma in a US Population
- (2013) Stuart C. Gordon et al. Clinical Gastroenterology and Hepatology
- Randomized Comparison of Tenofovir Disoproxil Fumarate vs Emtricitabine and Tenofovir Disoproxil Fumarate in Patients With Lamivudine-Resistant Chronic Hepatitis B
- (2013) Scott Fung et al. GASTROENTEROLOGY
- HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability
- (2013) Gi-Ae Kim et al. GUT
- Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients With liver cirrhosis
- (2013) Grace Lai-Hung Wong et al. HEPATOLOGY
- No detectable resistance to tenofovir disoproxil fumarate after 6 years of therapy in patients with chronic hepatitis B
- (2013) Kathryn M. Kitrinos et al. HEPATOLOGY
- Tenofovir Monotherapy and Tenofovir Plus Entecavir Combination as Rescue Therapy for Entecavir Partial Responders
- (2012) Benjamin Yip et al. DIGESTIVE DISEASES AND SCIENCES
- Is Hepatitis Virus Resistance to Antiviral Drugs a Threat?
- (2012) Jean–Michel Pawlotsky GASTROENTEROLOGY
- Efficacy of Entecavir With or Without Tenofovir Disoproxil Fumarate for Nucleos(t)ide-Naïve Patients With Chronic Hepatitis B
- (2012) Anna S. Lok et al. GASTROENTEROLOGY
- Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection
- (2012) Tetsuya Hosaka et al. HEPATOLOGY
- Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
- (2012) Yun-Fan Liaw et al. Hepatology International
- Management of treatment failure in chronic hepatitis B
- (2012) Fabien Zoulim et al. JOURNAL OF HEPATOLOGY
- Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: Finite treatment duration unlikely
- (2012) Stéphane Chevaliez et al. JOURNAL OF HEPATOLOGY
- Antiviral efficacy of combination therapy with entecavir and adefovir for entecavir/lamivudine-resistant hepatitis B virus with or without adefovir resistance
- (2012) Hyo-Joon Yang et al. JOURNAL OF MEDICAL VIROLOGY
- Entecavir plus adefovir combination treatment for chronic hepatitis B patients after failure of nucleoside/nucleotide analogues
- (2011) Young-Suk Lim et al. ANTIVIRAL THERAPY
- Comparison of multiplex restriction fragment mass polymorphism and sequencing analyses for detecting entecavir resistance in chronic hepatitis B
- (2011) Kyung Ho Han et al. ANTIVIRAL THERAPY
- Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: An international multicenter cohort study
- (2011) Jorg Petersen et al. JOURNAL OF HEPATOLOGY
- Response to tenofovir monotherapy in chronic hepatitis B patients with prior suboptimal response to entecavir
- (2011) C. Q. Pan et al. JOURNAL OF VIRAL HEPATITIS
- Antiviral resistance and hepatitis B therapy
- (2010) Marc G. Ghany et al. HEPATOLOGY
- Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B
- (2010) Ting-Tsung Chang et al. HEPATOLOGY
- Risk assessment for the development of hepatocellular carcinoma: According to on-treatment viral response during long-term lamivudine therapy in hepatitis B virus-related liver disease
- (2010) Jong Ryul Eun et al. JOURNAL OF HEPATOLOGY
- Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir
- (2009) Wilhelmus F. Leemans et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy
- (2009) Daniel J. Tenney et al. HEPATOLOGY
- Chronic hepatitis B: Update 2009
- (2009) Anna S. F. Lok et al. HEPATOLOGY
- Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
- (2008) Yun-Fan Liaw et al. Hepatology International
- Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
- (2008) Patrick Marcellin et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation